Olfura Plus Tablet belongs to a group of medicines known as 'urinary bladder relaxant' medication, used primarily in treating the enlarged prostate gland. Benign prostatic hyperplasia (enlarged prostate gland) is a non-cancerous growth of the prostate gland caused due to overproduction of a dihydrotestosterone hormone in men. As the gland enlarges, it can lead to urinary problems, such as difficulty passing urine and frequent urination. Olfura Plus Tablet helps in getting relief from these symptoms. Olfura Plus Tablet does not cure prostate cancer.

Olfura Plus Tablet contains Alfuzosin (alpha-blockers) and Dutasteride (5-alpha reductase inhibitor), primarily used to treat the enlarged prostate gland. Alfuzosin makes it easy to pass urine by relaxing the prostate gland muscles. Dutasteride reduces the enlarged prostate gland's size by lowering the production of dihydrotestosterone hormone, thereby relieving urinary incontinence symptoms that minimise the need for prostate surgery and the risk of acute urinary retention. Both of them collectively improve Benign Hyperplasia Prostate symptoms (BPH).

You are advised to take Olfura Plus Tablet for as long as your doctor has prescribed it for you, depending upon your medical condition. The most common side effects of Olfura Plus Tablet are dizziness, lightheadedness, drowsiness, sexual problems (decreased sex drive or libido), runny/stuffy nose, reduced amount of semen/sperm, testicle pain/swelling, increased breast size, or breast tenderness. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. 

Women or children should not take Olfura Plus Tablet. Please inform your doctor before starting Olfura Plus Tablet if you have low blood pressure, liver/kidney disease, or history of heart problems. It is advisable to use contraceptives (like a condom) while having sex if your wife is pregnant as Olfura Plus Tablet is known to pass in semen. Do not donate blood while taking Olfura Plus Tablet. However, you can donate it six months after the last dose of Olfura Plus Tablet.

Olfura Plus Tablet contains Alfuzosin (alpha-blockers) and dutasteride (5-alpha reductase inhibitor), primarily used in treating the enlarged prostate gland. As the gland enlarges, it can lead to urinary problems, such as difficulty passing urine and a frequent urination urge. Dutasteride lowers the production of dihydrotestosterone hormone, which leads to a decrease in the size of the prostate and, as a result, relieves the symptoms. This will reduce the risk of acute urinary retention and the need for surgery. Alfuzosin makes it easy to pass urine by relaxing the muscles of the gland. Both of them collectively improve Benign Hyperplasia Prostate symptoms (BPH).

Do not take Olfura Plus Tablet if you are allergic to any of its ingredients. Olfura Plus Tablet should not be taken if you have low blood pressure, which makes you feel dizzy, lightheaded, or faint, or if you have glaucoma. Inform your doctor if you have a history of heart disease or liver/kidney disease. Before undergoing surgery (cataract), please consult a doctor as you might be advised to stop Olfura Plus Tablet. During sexual intercourse, use a condom as Olfura Plus Tablet is found in semen. Contact your doctor for advice if you are pregnant or plan to get pregnant before taking Olfura Plus Tablet as it may affect the development of male genitals. Also, keep your doctor informed about all the OTC medicines you use. Patients taking Olfura Plus Tablet should be cautioned about driving, operating machinery, or performing hazardous tasks, as it can cause drowsiness or dizziness. In rare cases, problems of penis erection, ejaculation, and pain in the penis can occur. So if these symptoms last for a longer time, immediately contact your doctor.

• Consult your doctor immediately if you have symptoms such as shortness of breath, extreme tiredness, and swelling in your ankles and legs.
• Olfura Plus Tablet is not intended as an antihypertensive (blood pressure lowering) drug.
• Don't stand suddenly from a lying or resting position, which may increase the risk of falls.